Published • loading... • Updated
PTC Therapeutics (NASDAQ:PTCT) VP Sells 435 Shares of Company Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PTC Therapeutics (NASDAQ:PTCT) VP Sells 435 Shares of Company Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) VP Mark Boulding sold 435 shares of PTC Therapeutics stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $64.16, for a total transaction of $27,909.60. Following the completion of the sale, the vice president owned 105,272 shares in the company, valued at $6,754,251.52. This trade represents a 0.41% decrease in their ownership of the stoc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
